Search

everythinglearnresearchcommunity

for

Search:↓

The AAcQLI is a promising tool for assessing quality of life in children with alopecia areata.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

Generative AI tools like GPT-4o can effectively automate SALT scoring for alopecia areata, matching clinician accuracy.

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

Generative AI tools can accurately score alopecia areata, reducing subjectivity in evaluations.

Mutations in specific genes cause different types of ectodermal dysplasias.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

A natural hair treatment alternative to chemical straightening is being developed to reduce health risks.

The document does not provide the results or effectiveness of the green tea and gotukola extract hair growth treatment.

Finasteride at 1 mg daily doesn't help hair loss in postmenopausal women and has similar side effects to a placebo.

Baricitinib significantly regrows hair in severe alopecia areata patients.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Hair loss may indicate higher risk of heart disease.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

The Spanish version of the Hair Specific Skindex-29 is a reliable tool for measuring quality of life in Spanish-speaking women with hair loss.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

The Arabic Skindex-16 is a reliable and valid way to measure the impact of skin conditions on quality of life in Saudi patients.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

The Swedish Hairdex-S is a reliable tool for assessing quality of life in Alopecia Areata patients.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.